Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?

Lisa Bodei; Emily K. Bergsland; Wouter K. de Herder; Diego Ferone; Rodney J. Hicks; Thomas A. Hope; Jolanta A. Kunikowska; Marianne Pavel; Diane L Reidy-Lagunes; Jens Siveke; Jonathan R. Strosberg; Ulf Dittmer; Ken Herrmann

doi:10.2967/jnumed.120.249136

OtherEditorial

Open Access

Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?

Lisa Bodei, Emily K. Bergsland, Wouter K. de Herder, Diego Ferone, Rodney J. Hicks, Thomas A. Hope, Jolanta A. Kunikowska, Marianne Pavel, Diane L Reidy-Lagunes, Jens Siveke, Jonathan R. Strosberg, Ulf Dittmer and Ken Herrmann

Journal of Nuclear Medicine June 2020, jnumed.120.249136; DOI: https://doi.org/10.2967/jnumed.120.249136

Lisa Bodei

1 Memorial Sloan Kettering Cancer Center, Molecular Imaging and Therapy Service, Department of Radiology, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Emily K. Bergsland

2 University of California San Francisco, Division of Hematology/Oncology, Department of Medicine, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wouter K. de Herder

3 Erasmus MC & Erasmus MC Cancer Center, ENETS Center of Excellence Rotterdam;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Diego Ferone

4 University of Genova, Endocrinology Unit, Department of Internal Medicine and Medical Specialties (DIMI) and Centre of Excellence for Biomedical Research (CEBR), Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rodney J. Hicks

5 Peter MacCallum Cancer Institute, Department of Oncology, University of Melbourne, Australia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas A. Hope

6 University of California, San Francisco, Department of Radiology and Biomedical Imaging, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jolanta A. Kunikowska

7 Medical University of Warsaw, Nuclear Medicine Department, Poland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marianne Pavel

8 Friedrich-Alexander University Erlangen-Nürnberg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Diane L Reidy-Lagunes

9 Memorial Sloan Kettering Cancer Center, Gastrointestinal Oncology Service, Department of Medicine, United States;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jens Siveke

10 University Hospital Essen, West German Cancer Center, Institute for Developmental Cancer Therapeutics, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jonathan R. Strosberg

11 H. Lee Moffitt Cancer Center & Research Institute, Department of Gastrointestinal Oncology;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ulf Dittmer

12 University Hospital Essen, Institute for Virology, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

13 Department of Nuclear Medicine, University Hospital Essen, Germany and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.